replagal durchstechflasche à 3.5 ml infusionskonzentrat
takeda pharma ag - agalsidasum alfa - infusionskonzentrat - agalsidasum alfa 1 mg, natrii dihydrogenophosphas monohydricus, polysorbatum 20, natrii chloridum, natrii hydroxidum q.s. ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 4.1 mg. - enzymersatz terapia nei pazienti con malattia di fabry (alfa-galattosidasi a mancanza) - biotechnologika
equasym xr 10 mg; retardkapseln equasym xr 10 mg; retardkapseln
takeda pharma ag - methylphenidati hydrochloridum - equasym xr 10 mg; retardkapseln - methylphenidati hydrochloridum 10 mg, sacchari sphaerae corresp. saccharum 34.1-49.5 mg et maydis amylum, povidonum, hypromellosum, macrogola, ethylcellulosum, dibutylis sebacas, kapselhülle: gelatina, e 132, e 171, e 172 (flavum), drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, ammoniae solutio 28 per centum, e 171, e 172 (nigrum) pro capsula. - adhs, adhd - synthetika
equasym xr 20 mg; retardkapseln equasym xr 20 mg; retardkapseln
takeda pharma ag - methylphenidati hydrochloridum - equasym xr 20 mg; retardkapseln - methylphenidati hydrochloridum 20 mg, sacchari sphaerae corresp. saccharum 68.2-99.7 mg et maydis amylum, povidonum, hypromellosum, macrogola, ethylcellulosum, dibutylis sebacas, kapselhülle: gelatina, e 132, e 171, drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, ammoniae solutio 28 per centum, e 171, e 172 (nigrum) pro capsula. - adhs, adhd - synthetika
equasym xr 30 mg; retardkapseln equasym xr 30 mg; retardkapseln
takeda pharma ag - methylphenidati hydrochloridum - equasym xr 30 mg; retardkapseln - methylphenidati hydrochloridum 30 mg, sacchari sphaerae corresp. saccharum 102.3-149.8 mg et maydis amylum, povidonum, hypromellosum, macrogola, ethylcellulosum, dibutylis sebacas, kapselhülle: gelatina, e 132, e 171, e 172 (rubrum), drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, ammoniae solutio 28 per centum, e 171, e 172 (nigrum) pro capsula. - adhs, adhd - synthetika
elaprase 2 mg/ml infusionskonzentrat
takeda pharma ag - idursulfasum - infusionskonzentrat - idursulfasum 2 mg, natrii chloridum, dinatrii phosphas heptahydricus, natrii dihydrogenophosphas monohydricus, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.7 mg. - trattamento a lungo termine dei pazienti con hunter-sindrome (mucopolisaccaridosi ii, mps ii) - biotechnologika
fosrenol 500 mg compresse masticabili
takeda pharma ag - lantanio - compresse masticabili - lanthanum 500 mg ut lanthani(iii) carbonas hydricum 954 mg, saccharida hydrica corresp. glucosum 1055.736 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso. - sostanza che lega il fosfato - synthetika
fosrenol 750 mg compresse masticabili
takeda pharma ag - lantanio - compresse masticabili - lanthanum 750 mg ut lanthani(iii) carbonas hydricum 1431 mg, saccharida hydrica corresp. glucosum 1583.604 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso. - sostanza che lega il fosfato - synthetika
fosrenol 1000 mg compresse masticabili
takeda pharma ag - lantanio - compresse masticabili - lanthanum 1000 mg ut lanthani(iii) carbonas hydricum 1908 mg, saccharida hydrica corresp. glucosum 2111.472 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso. - sostanza che lega il fosfato - synthetika
firazyr 30 mg soluzione iniettabile
takeda pharma ag - icatibantum - soluzione iniettabile - icatibantum 10 mg ut icatibanti acetas, natrii chloridum, natrii hydroxidum, acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - trattamento di angioedema (treatment of angioedema) - synthetika
resolor 1 mg compresse rivestite con film
takeda pharma ag - prucalopridum - compresse rivestite con film - prucalopridum 1 mg ut prucalopridi succinas, lactosum monohydricum 149.969 mg, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, e 171, macrogolum 3000, triacetinum, lactosum monohydricum 1.32 mg, pro compresso obducto. - idiopatica cronica, stipsi negli adulti, per i quali la precedente terapia con misure dietetiche e lassativi non è sufficientemente efficace. - synthetika